Background. Acute respiratory distress syndrome (ARDS) is a very severe breathing problem with a high mortality rate (chance of dying). It has many potential causes, including viral infections such as ...

Acute respiratory distress syndrome (ARDS) is a life-threatening form of respiratory failure characterized by rapid-onset hypoxemia, diffuse lung inflammation, and noncardiogenic pulmonary edema, most ...

12. Acute Respiratory Distress Syndrome N, Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute ...

In the EU, GOHIBIC (vilobelimab) has been granted marketing authorization under exceptional circumstances for the treatment of adult patients with SARS-CoV-2-induced acute respiratory distress ...

JENA, Germany, Jan. 15, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced ...

ABSTRACT. Objective: To systematically review the effects of recruitment maneuvers on patients with acute respiratory distress syndrome. Methods: This systematic review and meta-analysis using the ...

Objective To determine whether neuromuscular blocking agents (NMBAs) can decrease the mortality of patients with acute respiratory distress syndrome (ARDS) and improve their clinical outcomes. Design ...

Acute respiratory distress syndrome - when fluid leaks into your lungs, making it hard to breathe There are more White people in the U.S. than people of color, so most people diagnosed with RSV ...

Acute respiratory distress in adults. Lancet. 1967;2(7511):319-23. 2 Cheifetz IM. Pediatric ARDS. Respir Care. 2017;62(6):718-31. 3 Parvathaneni K, Belani S, Leung D, Newth CJ, Khemani RG. ...

Introduction Hypoxaemic respiratory failure (HRF) affects nearly 15% of critically ill adults admitted to an intensive care unit (ICU). An evidence-based, stakeholder-informed multidisciplinary care ...